| 前收盘价格 | 143.27 |
| 收盘价格 | 145.32 |
| 成交量 | 857,320 |
| 平均成交量 (3个月) | 1,145,211 |
| 市值 | 11,178,829,824 |
| 市盈率 (P/E TTM) | 50.34 |
| 预期市盈率 (P/E Forward) | 13.95 |
| 价格/销量 (P/S) | 1.40 |
| 股市价格/股市净资产 (P/B) | 1.22 |
| 52周波幅 | |
| 利润日期 | 23 Jun 2026 |
| 营业毛利率 | 9.82% |
| 营业利益率 (TTM) | 12.83% |
| 稀释每股收益 (EPS TTM) | 9.71 |
| 季度收入增长率 (YOY) | -4.80% |
| 季度盈利增长率 (YOY) | 24.50% |
| 总债务/股东权益 (D/E MRQ) | 37.12% |
| 流动比率 (MRQ) | 1.29 |
| 营业现金流 (OCF TTM) | 1.16 B |
| 杠杆自由现金流 (LFCF TTM) | 901.28 M |
| 资产报酬率 (ROA TTM) | 4.35% |
| 股东权益报酬率 (ROE TTM) | 8.30% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Diagnostics & Research (US) | 混合的 | 看涨 |
| Diagnostics & Research (全球的) | 混合的 | 看涨 | |
| 股票 | ICON plc | 看跌 | 看跌 |
AIStockmoo 评分
0.4
| 分析师共识 | -2.0 |
| 内部交易活动 | NA |
| 价格波动 | -2.0 |
| 技术平均移动指标 | 3.5 |
| 技术振荡指标 | 2.0 |
| 平均 | 0.38 |
|
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland. |
|
| 部门 | Healthcare |
| 行业 | Diagnostics & Research |
| 投资方式 | Mid Value |
| 内部持股比例 | 0.63% |
| 机构持股比例 | 92.70% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Sachem Head Capital Management Lp | 31 Mar 2026 | 2,105,000 |
| Greenhaven Associates Inc | 31 Mar 2026 | 2,002,411 |
| Ruane, Cunniff & Goldfarb L.P. | 31 Mar 2026 | 1,634,611 |
| Madison Avenue Partners, Lp | 31 Mar 2026 | 1,282,838 |
| Trinity Street Asset Management Llp | 31 Mar 2026 | 1,208,148 |
该时间范围内无数据。
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合